• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

他扎罗汀泡沫用于寻常痤疮的治疗。

Use of tazarotene foam for the treatment of acne vulgaris.

作者信息

Gregoriou Stamatis, Kritsotaki Eleftheria, Katoulis Alexandros, Rigopoulos Dimitris

机构信息

Second Department of Dermatology and Venereology, Attikon Hospital, University of Athens Medical School, Athens, Greece.

出版信息

Clin Cosmet Investig Dermatol. 2014 May 27;7:165-70. doi: 10.2147/CCID.S37327. eCollection 2014.

DOI:10.2147/CCID.S37327
PMID:24920932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4043801/
Abstract

Acne vulgaris is a common inflammatory chronic disease of the pilosebaceous unit. It often requires long-term treatment, resulting in increased demand for topical medications that are popular with patients in order to achieve long-term compliance. Tazarotene foam 0.1% is a novel formulation of tazarotene. We review efficacy and tolerability studies of the new formulation, and suggest a possible place for the product in the management of acne vulgaris.

摘要

寻常痤疮是一种常见的毛囊皮脂腺单位慢性炎症性疾病。它通常需要长期治疗，这使得患者对局部用药的需求增加，以便实现长期依从性。0.1%他扎罗汀泡沫是他扎罗汀的一种新型制剂。我们回顾了这种新制剂的疗效和耐受性研究，并提出了该产品在寻常痤疮治疗中可能的应用位置。

相似文献

1
Use of tazarotene foam for the treatment of acne vulgaris.他扎罗汀泡沫用于寻常痤疮的治疗。
Clin Cosmet Investig Dermatol. 2014 May 27;7:165-70. doi: 10.2147/CCID.S37327. eCollection 2014.
2
Tazarotene foam, 0.1%, for the treatment of acne.0.1%的他扎罗汀泡沫剂用于治疗痤疮。
Expert Opin Drug Saf. 2016 Jan;15(1):99-103. doi: 10.1517/14740338.2016.1117605. Epub 2015 Nov 30.
3
Safety and efficacy of tazarotene foam for the treatment of acne vulgaris.他扎罗汀泡沫治疗寻常痤疮的安全性和有效性。
Clin Cosmet Investig Dermatol. 2013 May 14;6:123-5. doi: 10.2147/CCID.S34054. Print 2013.
4
The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.两项多中心、随机、赋形剂对照、双盲研究中，0.1%他扎罗汀泡沫治疗寻常痤疮的疗效和耐受性。
J Drugs Dermatol. 2013 Apr;12(4):438-46.
5
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.他扎罗汀0.045%洗剂每日一次治疗中度至重度寻常痤疮：两项3期试验结果
J Drugs Dermatol. 2020 Jan 1;19(1):70-77. doi: 10.36849/JDD.2020.3977.
6
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.与0.1%他扎罗汀凝胶相比，0.3%阿达帕林凝胶治疗寻常痤疮的疗效和耐受性。
J Drugs Dermatol. 2008 Jun;7(6 Suppl):s3-10.
7
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.0.1%他扎罗汀乳膏联合1%克林霉素凝胶与0.025%维甲酸凝胶联合1%克林霉素凝胶治疗寻常性面部痤疮的疗效比较
Dermatol Online J. 2007 Jul 13;13(3):1.
8
Topical Retinoids in Acne Vulgaris: A Systematic Review.寻常痤疮的局部用维 A 酸类药物：系统评价。
Am J Clin Dermatol. 2019 Jun;20(3):345-365. doi: 10.1007/s40257-019-00423-z.
9
Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.他扎罗汀0.045%洗剂用于成年男性中重度寻常痤疮的每日一次治疗。
J Drugs Dermatol. 2020 Jan 1;19(1):78-85. doi: 10.36849/JDD.2020.3979.
10
Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems.维甲酸在寻常痤疮治疗中的靶向局部递送：当前制剂与新型递送系统
Pharmaceutics. 2019 Sep 24;11(10):490. doi: 10.3390/pharmaceutics11100490.

引用本文的文献

1
The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne.当前合成化合物以及可能的植物和海洋植物化学化合物在痤疮治疗中的作用。
RSC Adv. 2024 Aug 5;14(33):24287-24321. doi: 10.1039/d4ra03865g. eCollection 2024 Jul 26.
2
Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies.探索痤疮治疗：从病理生理学机制到新兴疗法。
Int J Mol Sci. 2024 May 13;25(10):5302. doi: 10.3390/ijms25105302.
3
Vitamins for the Management of Nail Disease: A Literature Review.用于指甲疾病管理的维生素：文献综述
Skin Appendage Disord. 2024 Apr;10(2):104-122. doi: 10.1159/000534972. Epub 2023 Nov 23.
4
Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances.寻常痤疮：病理生理学、治疗及基于纳米技术的最新进展综述
Biochem Biophys Rep. 2023 Nov 23;36:101578. doi: 10.1016/j.bbrep.2023.101578. eCollection 2023 Dec.
5
Tackling acne vulgaris by fabrication of tazarotene-loaded essential oil-based microemulsion: and evaluation.通过制备载有他扎罗汀的精油基微乳液治疗寻常痤疮：及其评估。
Int J Pharm X. 2023 May 29;5:100185. doi: 10.1016/j.ijpx.2023.100185. eCollection 2023 Dec.
6
Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes.统计序贯实验：初步混合因子设计、I-最优混合设计，最后是用于他扎罗汀立方液晶纳米粒优化的新型设计空间扩展
Int J Nanomedicine. 2022 Mar 12;17:1069-1086. doi: 10.2147/IJN.S337130. eCollection 2022.
7
Foray into Concepts of Design and Evaluation of Microemulsions as a Modern Approach for Topical Applications in Acne Pathology.初探微乳剂的设计与评价概念，微乳剂是痤疮病理学局部应用的一种现代方法。
Nanomaterials (Basel). 2020 Nov 19;10(11):2292. doi: 10.3390/nano10112292.
8
Photostability Testing of a Third-Generation Retinoid-Tazarotene in the Presence of UV Absorbers.在紫外线吸收剂存在的情况下对第三代维甲酸类药物——他扎罗汀进行光稳定性测试。
Pharmaceutics. 2020 Sep 22;12(9):899. doi: 10.3390/pharmaceutics12090899.
9
Time-resolved fluorescence microscopy with phasor analysis for visualizing multicomponent topical drug distribution within human skin.相衬分析的时间分辨荧光显微镜用于可视化人皮肤内多组分局部药物分布。
Sci Rep. 2020 Mar 24;10(1):5360. doi: 10.1038/s41598-020-62406-z.
10
Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac) Cream 0.1.0.1% 短接触他扎罗汀洗剂与 0.1% 他扎罗汀（Tazorac）乳膏的生物利用度、药代动力学及经皮水分流失比较
J Clin Aesthet Dermatol. 2019 Sep;12(9):16-24. Epub 2019 Sep 1.

本文引用的文献

1
Safety and efficacy of tazarotene foam for the treatment of acne vulgaris.他扎罗汀泡沫治疗寻常痤疮的安全性和有效性。
Clin Cosmet Investig Dermatol. 2013 May 14;6:123-5. doi: 10.2147/CCID.S34054. Print 2013.
2
Acne vulgaris.寻常痤疮
BMJ. 2013 May 8;346:f2634. doi: 10.1136/bmj.f2634.
3
The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.两项多中心、随机、赋形剂对照、双盲研究中，0.1%他扎罗汀泡沫治疗寻常痤疮的疗效和耐受性。
J Drugs Dermatol. 2013 Apr;12(4):438-46.
4
A status report on topical tazarotene in the management of acne vulgaris.外用他扎罗汀治疗寻常痤疮的现状报告。
J Drugs Dermatol. 2013 Mar;12(3):s53-8.
5
Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris.他扎罗汀泡沫剂与他扎罗汀凝胶剂：寻常痤疮随机相对生物利用度研究。
Clin Drug Investig. 2013 Apr;33(4):283-9. doi: 10.1007/s40261-013-0065-1.
6
Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.在两项1期斑贴试验中0.1%他扎罗汀泡沫的光毒性和光变应性潜力
Cutis. 2012 Nov;90(5):266-71.
7
Cumulative irritation potential and contact sensitization potential of tazarotene foam 0.1% in 2 phase 1 patch studies.在两项1期斑贴试验中，0.1%他扎罗汀泡沫的累积刺激潜力和接触致敏潜力。
Cutis. 2012 Oct;90(4):206-11.
8
The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece. Results of a population survey.寻常痤疮对希腊青少年生活质量和心理健康的影响。一项人口调查的结果。
An Bras Dermatol. 2012 Nov-Dec;87(6):862-9. doi: 10.1590/s0365-05962012000600007.
9
European evidence-based (S3) guidelines for the treatment of acne.欧洲痤疮治疗循证（S3）指南
J Eur Acad Dermatol Venereol. 2012 Feb;26 Suppl 1:1-29. doi: 10.1111/j.1468-3083.2011.04374.x.
10
[S2k-guideline for therapy of acne].[严重寻常痤疮治疗的S2k指南]
J Dtsch Dermatol Ges. 2010 Jul;8 Suppl 2:s1-59. doi: 10.1111/j.1610-0387.2010.07466.x.